Literature DB >> 18034331

[Botulinum toxin for the treatment of overactive bladder--an overview].

C Seif1, S Boy, B Wefer, R Dmochowski, P M Braun, K-P Jünemann.   

Abstract

This article shall give a state-of-the-art review about the treatment of neurogenic and idiopathic detrusor overactivity with botulinum toxin injections into the detrusor muscle. We searched PubMed for original articles up to December 2006. Abstracts published at international congresses were also considered if they provided substantial new information. Based on this review it appears that a majority of patients with spinal cord injury regains continence after botulinum toxin A injection and that in children with myelomeningocele a significant improvement in continence can also be achieved. A concomitant reduction of intravesical pressure protects the upper urinary tract in these patients. In idiopathic detrusor overactivity, injection of botulinum toxin A also resulted in improvement of continence and reduction of daily micturition frequency. For both indications a high success rate could be achieved with an average duration of the effect of 6 months. Repeated injections into the detrusor seem to have no adverse effects in terms of duration or strength of the effect. Side effects were marginal and systemic side effects were experienced only in individual cases; in some patients with idiopathic detrusor overactivity intermittent self-catheterization was required. Overall intradetrusor injections of botulinum toxin seem to be a new, highly effective, and safe alternative in the treatment of neurogenic and idiopathic detrusor overactivity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18034331     DOI: 10.1007/s00120-007-1592-2

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  38 in total

1.  Treatment of neurogenic incontinence with botulinum toxin A.

Authors:  B Schurch; D M Schmid; M Stöhrer
Journal:  N Engl J Med       Date:  2000-03-02       Impact factor: 91.245

2.  Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study.

Authors:  Antonella Giannantoni; Savino M Di Stasi; Robert L Stephen; Vittorio Bini; Elisabetta Costantini; Massimo Porena
Journal:  J Urol       Date:  2004-07       Impact factor: 7.450

3.  Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.

Authors:  D M Schmid; P Sauermann; M Werner; B Schuessler; N Blick; M Muentener; R T Strebel; D Perucchini; D Scheiner; G Schaer; H John; A Reitz; D Hauri; B Schurch
Journal:  J Urol       Date:  2006-07       Impact factor: 7.450

4.  Efficacy of botulinum-A toxin in adults with neurogenic overactive bladder: initial results.

Authors:  S Hajebrahimi; W Altaweel; J Cadoret; E Cohen; J Corcos
Journal:  Can J Urol       Date:  2005-02       Impact factor: 1.344

5.  Botulinum-A toxin detrusor and sphincter injection in treatment of overactive bladder syndrome: objective outcome and patient satisfaction.

Authors:  Heinrich Schulte-Baukloh; Catarina Weiss; Thomas Stolze; Jaqueline Herholz; Burkard Stürzebecher; Kurt Miller; Helmut H Knispel
Journal:  Eur Urol       Date:  2005-07-18       Impact factor: 20.096

6.  Therapeutic effects of suburothelial injection of botulinum a toxin for neurogenic detrusor overactivity due to chronic cerebrovascular accident and spinal cord lesions.

Authors:  Hann-Chorng Kuo
Journal:  Urology       Date:  2006-01-25       Impact factor: 2.649

7.  Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study.

Authors:  Brigitte Schurch; Marianne de Sèze; Pierre Denys; Emmanuel Chartier-Kastler; Francois Haab; Karel Everaert; Pierre Plante; Brigitte Perrouin-Verbe; Catherine Kumar; Stephanie Fraczek; Mitchell F Brin
Journal:  J Urol       Date:  2005-07       Impact factor: 7.450

8.  [Minimally invasive, safe treatment of the neurogenic bladder with botulinum-A-toxin in children with myelomeningocele].

Authors:  L Lusuardi; A Nader; M Koen; A Schrey; M Schindler; M Riccabona
Journal:  Aktuelle Urol       Date:  2004-02       Impact factor: 0.658

9.  Botulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia.

Authors:  Marcus Riccabona; Mark Koen; Monica Schindler; Beckers Goedele; Armin Pycha; Lukas Lusuardi; Stuart B Bauer
Journal:  J Urol       Date:  2004-02       Impact factor: 7.450

10.  Use of botulinum-A toxin for the treatment of refractory overactive bladder symptoms: an initial experience.

Authors:  David E Rapp; Alvaro Lucioni; Erin E Katz; R Corey O'Connor; Glenn S Gerber; Gregory T Bales
Journal:  Urology       Date:  2004-06       Impact factor: 2.649

View more
  5 in total

1.  [Urinary incontinence in men and women. Diagnostics and conservative therapy].

Authors:  M F Hamann; K P Jünemann; C M Naumann
Journal:  Urologe A       Date:  2014-07       Impact factor: 0.639

Review 2.  [Therapy-refractory overactive bladder: alternative treatment approaches].

Authors:  S Knüpfer; M Hamann; C M Naumann; D Melchior; K-P Jünemann
Journal:  Urologe A       Date:  2011-07       Impact factor: 0.639

3.  [Effects of botulinum toxin type A in the single and repeated treatment of overactive bladder. A prospective analysis].

Authors:  C Frohme; Z Varga; P Olbert; A J Schrader; R Hofmann; A Hegele
Journal:  Urologe A       Date:  2010-05       Impact factor: 0.639

Review 4.  Urinary incontinence in women: part 1 of a series of articles on incontinence.

Authors:  Christian Dannecker; Klaus Friese; Christian Stief; Ricarda Bauer
Journal:  Dtsch Arztebl Int       Date:  2010-06-18       Impact factor: 5.594

5.  [Pharmacotherapy of urinary incontinence in the elderly].

Authors:  K F Becher
Journal:  Internist (Berl)       Date:  2016-04       Impact factor: 0.743

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.